Ian Rentsch recently became Vice President of Growth and Strategic Partnerships at Aetion. He previously held roles in clinical research and development and in global RWD (real world data) companies. In a recent discussion, he offers his opinions regarding the state of RWE (real world evidence) and how it can support research and development.
He remarks, “Sourcing and accessing RWD is a bit like finding grapes, and turning these into RWE is like making wine. The magic of Aetion is making great “wine” by applying our technology and regulatory-grade analytics to the data. I look forward to matching Aetion with great “grapes” from around the world, and making the best wine.” Learn more here.
(Source: Aetion, 2/4/21)